CUL4B mutations impair human cortical neurogenesis through PP2A-dependent inhibition of AKT and ERK

Yanyan Ma1, Xiaolin Liu1, Min Zhou1

  • 1Key Laboratory of Experimental Teratology, Ministry of Education, Institute of Molecular Medicine and Genetics, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250012, China.

Cell Death & Disease
|February 8, 2024
PubMed

Insights

Mutations in the CUL4B gene cause X-linked intellectual disability (XLID) by disrupting neural progenitor cell development. This leads to premature cell cycle exit and altered neuronal differentiation, impacting brain development.

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • X-linked intellectual disability (XLID) is often caused by mutations in the CUL4B gene.
  • CUL4B protein functions as a scaffold in the CRL4B ubiquitin ligase complex.
  • Mechanisms linking CUL4B mutations to neurological disorders remain unclear.

Purpose of the Study:

  • Investigate the role of CUL4B in human cortical development.
  • Elucidate the molecular mechanisms underlying neurological deficits in CUL4B mutation carriers.

Main Methods:

  • Utilized patient-derived induced pluripotent stem cells (iPSCs) and isogenic controls.
  • Employed 2D neuronal cultures and cerebral organoid models.
  • Analyzed gene transcription, protein activity, and cellular processes.

Main Results:

  • CUL4B deficiency causes premature cell cycle exit and precocious neuronal differentiation in neural progenitor cells.
  • CUL4B loss-of-function leads to increased synapse formation and neuronal excitability.
  • CRL4B complex normally represses PPP2R2B/C transcription via H2AK119 monoubiquitination, and its loss upregulates PP2A activity, inhibiting AKT/ERK signaling.

Conclusions:

  • CUL4B is essential for preventing premature cell cycle exit and ensuring proper neuronal differentiation during human cortical development.
  • CUL4B mutations disrupt neurogenesis through PP2A/AKT/ERK pathway dysregulation.
  • Restoring AKT/ERK activity or inhibiting PP2A rescues neurodevelopmental defects in CUL4B-mutant models.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K